高脂血症性急性胰腺炎与胆源性急性胰腺炎的凝血功能及疾病严重程度比较研究
该回顾性队列研究纳入2018年1月至2023年2月首都医科大学附属北京友谊医院感染内科与重症医学科收治的204例胆源性急性胰腺炎(BAP)和98例高脂血症性急性胰腺炎(HLAP)患者。按改良Atlanta标准分为轻症(MAP)、中度重症(MSAP)和重症(SAP),比较凝血指标及病情严重程度评分。结果显示,在MAP、MSAP和SAP各亚组中,HLAP患者的Fbg水平均显著高于BAP;在SAP亚组中,HLAP的FDP、D-二聚体、DIC评分、APACHE II评分、CTSI评分及改良Marshall评分均显著高于BAP。Logistic回归显示DIC评分(OR=1.32,95%CI 1.01-1.54,P=0.040)和FDP水平(OR=1.08,95%CI 1.05-1.11,P<0.001)是影响急性胰腺炎严重程度的因素。结论认为HLAP患者凝血紊乱及临床病程较BAP更重,凝血紊乱与急性胰腺炎病情严重程度相关。
要点
- 在SAP亚组中,HLAP患者DIC评分3.00(3.00,3.00)vs BAP 2.00(2.00,3.00),FDP 21.34(12.70,29.86)mg/L vs 12.13(5.65,21.30)mg/L,均P<0.05。
- 在SAP亚组中,HLAP患者D-二聚体6.54(4.35,9.15)mg/L vs BAP 3.89(1.58,6.23)mg/L,APACHE II评分11.00(7.75,16.25)vs 8.00(5.75,12.00),均P<0.05。
- 在MAP亚组中,HLAP患者Fbg 5.83(3.59,6.83)g/L vs BAP 3.47(2.70,4.28)g/L,CTSI评分2.00(1.50,2.50)vs 1.50(0.00,2.00),均P<0.05。
- 在MSAP亚组中,HLAP患者Fbg 6.42(4.66,7.31)g/L vs BAP 3.55(2.96,5.09)g/L,D-二聚体2.10(1.40,5.20)mg/L vs 1.30(0.81,2.28)mg/L,均P<0.05。
- Logistic回归显示DIC评分(OR=1.32,95%CI 1.01-1.54,P=0.040)和FDP水平(OR=1.08,95%CI 1.05-1.11,P<0.001)是影响急性胰腺炎严重程度的因素。
适用人群与场景
- 2018年1月至2023年2月首都医科大学附属北京友谊医院感染内科与重症医学科收治的HLAP和BAP患者。
- 按改良Atlanta标准分为MAP、MSAP和SAP;BAP共204例(MAP 70例、MSAP 64例、SAP 70例),HLAP共98例(MAP 25例、MSAP 35例、SAP 38例)。
诊断标准与关键阈值
- 采用改良Atlanta标准将急性胰腺炎分为轻症(MAP)、中度重症(MSAP)和重症(SAP)。
- 凝血功能评估指标包括PT、APTT、INR、AT-III、FDP、Fbg、D-二聚体和DIC评分。
- 病情严重程度采用SOFA评分、APACHE II评分、改良Marshall评分和CTSI评分评估。
研究设计与关键结果
- 研究类型为回顾性队列研究,纳入BAP 204例和HLAP 98例,比较凝血功能与疾病严重程度。
- MAP亚组:HLAP患者Fbg 5.83(3.59,6.83)g/L vs BAP 3.47(2.70,4.28)g/L,CTSI评分2.00(1.50,2.50)vs 1.50(0.00,2.00),均P<0.05。
- MSAP亚组:HLAP患者Fbg 6.42(4.66,7.31)g/L vs BAP 3.55(2.96,5.09)g/L,D-二聚体2.10(1.40,5.20)mg/L vs 1.30(0.81,2.28)mg/L,均P<0.05。
- SAP亚组:HLAP患者Fbg 6.28(4.67,7.79)g/L vs BAP 3.88(2.87,6.28)g/L,FDP 21.34(12.70,29.86)mg/L vs 12.13(5.65,21.30)mg/L,D-二聚体6.54(4.35,9.15)mg/L vs 3.89(1.58,6.23)mg/L,DIC评分3.00(3.00,3.00)vs 2.00(2.00,3.00),APACHE II评分11.00(7.75,16.25)vs 8.00(5.75,12.00),CTSI评分4.00(2.00,4.75)vs 2.00(1.00,4.00),改良Marshall评分2.00(1.00,3.00)vs 1.00(1.00,2.00),均P<0.05。
- Logistic回归分析显示DIC评分是影响急性胰腺炎严重程度的因素(OR=1.32,95%CI 1.01-1.54,P=0.040),FDP水平也是影响因素(OR=1.08,95%CI 1.05-1.11,P<0.001)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为HLAP患者较BAP患者凝血紊乱更重、临床病程更重,凝血紊乱与急性胰腺炎病情严重程度相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare coagulation function and disease severity between hyperlipidemic acute pancreatitis (HLAP) and biliary acute pancreatitis (BAP), and assess the relationship between coagulation disorder and disease severity.
METHODS: A retrospective cohort study was conducted. Patients diagnosed with HLAP and BAP who were admitted to the department of infectious diseases and intensive care medicine of Beijing Friendship Hospital of Capital Medical University from January 2018 to February 2023 were enrolled. Clinical data and laboratory indicators were collected, and evaluate their coagulation function through prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), antithrombin- III (AT- III), fibrinogen degradation products (FDP), fibrinogen (Fbg), D-dimer, and disseminated intravascular coagulation (DIC) score; the severity of the disease was measured by the sequential organ failure assessment (SOFA), acute physiology and chronic health evaluation II (APACHE II), modified Marshall score, and CT severity index (CTSI) score. According to the modified Atlanta criteria, patients were classified into mild acute pancreatitis (MAP), moderate severe acute pancreatitis (MSAP), and severe acute pancreatitis (SAP). Logistic regression analysis was performed to evaluate the relationship between coagulation disorder and disease severity.
RESULTS: A total of 204 patients with BAP (MAP 70, MSAP 64, SAP 70) and 98 patients with HLAP (MAP 25, MSAP 35, SAP 38) were included. In patients with MAP, HLAP patients had significantly higher Fbg level and CTSI score compared with BAP patients [Fbg (g/L): 5.83 (3.59, 6.83) vs. 3.47 (2.70, 4.28), CTSI score: 2.00 (1.50, 2.50) vs. 1.50 (0.00, 2.00), both P < 0.05]. In patients with MSAP, the levels of Fbg and D-dimer in HLAP were significantly higher than those in BAP [Fbg (g/L): 6.42 (4.66, 7.31) vs. 3.55 (2.96, 5.09), D-dimer (mg/L): 2.10 (1.40, 5.20) vs. 1.30 (0.81, 2.28), both P < 0.05]. In patients with SAP, HLAP patients had significantly higher levels of Fbg, FDP, D-dimer, and DIC score, APACHE II score, CTSI score, and modified Marshall score compared with BAP patients [Fbg (g/L): 6.28 (4.67, 7.79) vs. 3.88 (2.87, 6.28), FDP (mg/L): 21.34 (12.70, 29.86) vs. 12.13 (5.65, 21.30), D-dimer (mg/L): 6.54 (4.35, 9.15) vs. 3.89 (1.58, 6.23), DIC score: 3.00 (3.00, 3.00) vs. 2.00 (2.00, 3.00), APACHE II score: 11.00 (7.75, 16.25) vs. 8.00 (5.75, 12.00), CTSI score: 4.00 (2.00, 4.75) vs. 2.00 (1.00, 4.00), modified Marshall score: 2.00 (1.00, 3.00) vs. 1.00 (1.00, 2.00), all P < 0.05]. Logistic regression analysis demonstrated that the DIC score as a factor affecting the severity of acute pancreatitis [odds ratio (OR) = 1.32, 95% confidence interval (95%CI) was 1.01-1.54, P = 0.040], FDP level also as a factor affecting the severity of acute pancreatitis (OR = 1.08, 95%CI was 1.05-1.11, P < 0.001).
CONCLUSIONS: Patients with HLAP exhibited more severe coagulation disorders and clinical courses than those with BAP, and coagulation disorders were associated with disease severity in acute pancreatitis.
参考来源
- Wang X, Qi W. [A comparative study of coagulation function and disease severity between hyperlipidemic acute pancreatitis and biliary acute pancreatitis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41437588. doi:10.3760/cma.j.cn121430-20250206-00101
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。